Correction: Ciardiello et al. Biomarker-Guided Anti-EGFR Rechallenge Therapy in Metastatic Colorecta...
Correction: Ciardiello et al. Biomarker-Guided Anti-EGFR Rechallenge Therapy in Metastatic Colorectal Cancer. Cancers 2021, 13, 1941
About this item
Full title
Author / Creator
Publisher
Basel: MDPI AG
Journal title
Language
English
Formats
Publication information
Publisher
Basel: MDPI AG
Subjects
More information
Scope and Contents
Contents
Study Study Type Number of Patients Rechallenge Treatment RR mPFS mOS Santini et al., 2012 [11] Retrospective 39 FOLFIRI + Cetuximab Irinotecan + Cetuximab 53.8% 6.6 m NR CRICKET Prospective 28 Irinotecan + Cetuximab 21.4% 3.4 m 9.8 CRICKET (RAS ctDNA WT) Prospective 13 Irinotecan + Cetuximab 31% 4 m 12.5 m CRICKET (RAS ctDNA MUT) Prospective 12 Ir...
Alternative Titles
Full title
Correction: Ciardiello et al. Biomarker-Guided Anti-EGFR Rechallenge Therapy in Metastatic Colorectal Cancer. Cancers 2021, 13, 1941
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9406023
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9406023
Other Identifiers
ISSN
2072-6694
E-ISSN
2072-6694
DOI
10.3390/cancers14163900
